‘Manogram’ draws attention of federal lawmakers
Last year, a group lobbying for government funds to develop better ways to detect prostate cancer launched a public awareness program with an iconic spokesgland. Prosty’s lighthearted delivery of a no-nonsense message about prostate cancer appears to be paying off.
Last year, a group lobbying for government funds to develop better ways to detect prostate cancer launched a public awareness program with an iconic spokesgland. Prosty's lighthearted delivery of a no-nonsense message about prostate cancer appears to be paying off.
The AdMeTech Foundation, which developed the campaign, announced last week that 43 members of the U.S. House of Representatives have cosigned a bipartisan bill, HR 863, that calls for increased attention to and investment in prostate imaging and image-guided minimally invasive treatment for prostate cancer.
The foundation developed and championed this resolution in cooperation with Rep. Elijah Cummings (D-MD), a senior member of Congress and former chair of the Congressional Black Caucus.
The resolution "expresses the sense of the House of Representatives" that there should be an increased federal commitment to supporting the development of innovative advanced imaging technologies for prostate cancer detection and treatment, according to the legislation. HR 863 notes that prostate cancer has reached epidemic proportions, striking at least one in six men in the U.S., with African Americans having a 60% higher incidence than whites and a mortality rate twice as high.
The resolution calls for Congress and the executive branch to provide additional support for the research and development of technologies for prostate cancer detection and treatment comparable to state-of-the-art mammograms.
For further information from the Diagnostic Imaging archives:
Seven Takeaways from Meta-Analysis of PSMA Radiotracers for Prostate Cancer Imaging
December 1st 2023In a newly published meta-analysis of 24 studies, researchers noted that the PSMA PET radiotracer 18F PSMA-1007 may provide more benefit than 68Ga Ga-PSMA-11 for primary staging of patients with prostate cancer and detection of local lesion recurrence, but also has drawbacks with higher liver uptake and multiple reports of false positive bone lesions.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.
Chest CT Study Shows Higher Emphysema Risk from Combination of Marijuana and Cigarette Smoking
November 28th 2023People who smoke marijuana and cigarettes have 12 times the risk for centrilobular emphysema than non-smokers, according to new computed tomography (CT) research presented at the annual Radiological Society of North America (RSNA) conference.
